Functional expression of P2Y receptors in WERI-Rb1 retinoblastoma cells

Na Hyun Kim, Kyu Sang Park, Joon Hyung Sohn, Byung Il Yeh, Chang Mann Ko, In Deok Kong

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

P2Y receptors are metabotropic G-protein-coupled receptors, which are involved in many important biologic functions in the central nervous system including retina. Subtypes of P2Y receptors in retinal tissue vary according to the species and the cell types. We examined the molecular and pharmacologic profiles of P2Y purinoceptors in retinoblastoma cell, which has not been identified yet. To achieve this goal, we used Ca2+ imaging technique and western blot analysis in WERI-Rb-1 cell, a human retinoblastoma cell line. ATP (10 μM) elicited strong but transient [Ca2+]i increase in a concentration-dependent manner from more than 80% of the WERI-Rb-1 cells (n=46). Orders of potency of P2Y agonists in evoking [Ca 2+]i transients were 2MeS-ATP>ATP≫UTP= αβ -MeATP, which was compatible with the subclass of P2Y1 receptor. The [Ca2+]i transients evoked by applications of 2MeS-ATP and/or ATP were also profoundly suppressed in the presence of P2Y1 selective blocker (MRS 2179; 30 μM). P2Y1 receptor expression in WERI-Rb-1 cells was also identified by using western blot. Taken together, P2Y1 receptor is mainly expressed in a retinoblastoma cell, which elicits Ca2+ release from internal Ca storage sites via the phospholipase C-mediated pathway. P2Y1 receptor activation in retino-blastoma cell could be a useful model to investigate the role of purinergic [Ca2+]i signaling in neural tissue as well as to find a novel therapeutic target to this lethal cancer.

Original languageEnglish
Pages (from-to)61-66
Number of pages6
JournalKorean Journal of Physiology and Pharmacology
Volume15
Issue number1
DOIs
Publication statusPublished - 2011 Feb 1

Fingerprint

Retinoblastoma
Purinergic P2Y1 Receptors
Adenosine Triphosphate
Purinergic P2Y Receptors
Western Blotting
Type C Phospholipases
G-Protein-Coupled Receptors
Retina
Central Nervous System
Cell Line
Neoplasms

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pharmacology

Cite this

Kim, Na Hyun ; Park, Kyu Sang ; Sohn, Joon Hyung ; Yeh, Byung Il ; Ko, Chang Mann ; Kong, In Deok. / Functional expression of P2Y receptors in WERI-Rb1 retinoblastoma cells. In: Korean Journal of Physiology and Pharmacology. 2011 ; Vol. 15, No. 1. pp. 61-66.
@article{6d10fc9f30ce4981b06c629a2d3412ee,
title = "Functional expression of P2Y receptors in WERI-Rb1 retinoblastoma cells",
abstract = "P2Y receptors are metabotropic G-protein-coupled receptors, which are involved in many important biologic functions in the central nervous system including retina. Subtypes of P2Y receptors in retinal tissue vary according to the species and the cell types. We examined the molecular and pharmacologic profiles of P2Y purinoceptors in retinoblastoma cell, which has not been identified yet. To achieve this goal, we used Ca2+ imaging technique and western blot analysis in WERI-Rb-1 cell, a human retinoblastoma cell line. ATP (10 μM) elicited strong but transient [Ca2+]i increase in a concentration-dependent manner from more than 80{\%} of the WERI-Rb-1 cells (n=46). Orders of potency of P2Y agonists in evoking [Ca 2+]i transients were 2MeS-ATP>ATP≫UTP= αβ -MeATP, which was compatible with the subclass of P2Y1 receptor. The [Ca2+]i transients evoked by applications of 2MeS-ATP and/or ATP were also profoundly suppressed in the presence of P2Y1 selective blocker (MRS 2179; 30 μM). P2Y1 receptor expression in WERI-Rb-1 cells was also identified by using western blot. Taken together, P2Y1 receptor is mainly expressed in a retinoblastoma cell, which elicits Ca2+ release from internal Ca storage sites via the phospholipase C-mediated pathway. P2Y1 receptor activation in retino-blastoma cell could be a useful model to investigate the role of purinergic [Ca2+]i signaling in neural tissue as well as to find a novel therapeutic target to this lethal cancer.",
author = "Kim, {Na Hyun} and Park, {Kyu Sang} and Sohn, {Joon Hyung} and Yeh, {Byung Il} and Ko, {Chang Mann} and Kong, {In Deok}",
year = "2011",
month = "2",
day = "1",
doi = "10.4196/kjpp.2011.15.1.61",
language = "English",
volume = "15",
pages = "61--66",
journal = "Korean Journal of Physiology and Pharmacology",
issn = "1226-4512",
publisher = "Korean Physiological Soc. and Korean Soc. of Pharmacology",
number = "1",

}

Functional expression of P2Y receptors in WERI-Rb1 retinoblastoma cells. / Kim, Na Hyun; Park, Kyu Sang; Sohn, Joon Hyung; Yeh, Byung Il; Ko, Chang Mann; Kong, In Deok.

In: Korean Journal of Physiology and Pharmacology, Vol. 15, No. 1, 01.02.2011, p. 61-66.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Functional expression of P2Y receptors in WERI-Rb1 retinoblastoma cells

AU - Kim, Na Hyun

AU - Park, Kyu Sang

AU - Sohn, Joon Hyung

AU - Yeh, Byung Il

AU - Ko, Chang Mann

AU - Kong, In Deok

PY - 2011/2/1

Y1 - 2011/2/1

N2 - P2Y receptors are metabotropic G-protein-coupled receptors, which are involved in many important biologic functions in the central nervous system including retina. Subtypes of P2Y receptors in retinal tissue vary according to the species and the cell types. We examined the molecular and pharmacologic profiles of P2Y purinoceptors in retinoblastoma cell, which has not been identified yet. To achieve this goal, we used Ca2+ imaging technique and western blot analysis in WERI-Rb-1 cell, a human retinoblastoma cell line. ATP (10 μM) elicited strong but transient [Ca2+]i increase in a concentration-dependent manner from more than 80% of the WERI-Rb-1 cells (n=46). Orders of potency of P2Y agonists in evoking [Ca 2+]i transients were 2MeS-ATP>ATP≫UTP= αβ -MeATP, which was compatible with the subclass of P2Y1 receptor. The [Ca2+]i transients evoked by applications of 2MeS-ATP and/or ATP were also profoundly suppressed in the presence of P2Y1 selective blocker (MRS 2179; 30 μM). P2Y1 receptor expression in WERI-Rb-1 cells was also identified by using western blot. Taken together, P2Y1 receptor is mainly expressed in a retinoblastoma cell, which elicits Ca2+ release from internal Ca storage sites via the phospholipase C-mediated pathway. P2Y1 receptor activation in retino-blastoma cell could be a useful model to investigate the role of purinergic [Ca2+]i signaling in neural tissue as well as to find a novel therapeutic target to this lethal cancer.

AB - P2Y receptors are metabotropic G-protein-coupled receptors, which are involved in many important biologic functions in the central nervous system including retina. Subtypes of P2Y receptors in retinal tissue vary according to the species and the cell types. We examined the molecular and pharmacologic profiles of P2Y purinoceptors in retinoblastoma cell, which has not been identified yet. To achieve this goal, we used Ca2+ imaging technique and western blot analysis in WERI-Rb-1 cell, a human retinoblastoma cell line. ATP (10 μM) elicited strong but transient [Ca2+]i increase in a concentration-dependent manner from more than 80% of the WERI-Rb-1 cells (n=46). Orders of potency of P2Y agonists in evoking [Ca 2+]i transients were 2MeS-ATP>ATP≫UTP= αβ -MeATP, which was compatible with the subclass of P2Y1 receptor. The [Ca2+]i transients evoked by applications of 2MeS-ATP and/or ATP were also profoundly suppressed in the presence of P2Y1 selective blocker (MRS 2179; 30 μM). P2Y1 receptor expression in WERI-Rb-1 cells was also identified by using western blot. Taken together, P2Y1 receptor is mainly expressed in a retinoblastoma cell, which elicits Ca2+ release from internal Ca storage sites via the phospholipase C-mediated pathway. P2Y1 receptor activation in retino-blastoma cell could be a useful model to investigate the role of purinergic [Ca2+]i signaling in neural tissue as well as to find a novel therapeutic target to this lethal cancer.

UR - http://www.scopus.com/inward/record.url?scp=79953121218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953121218&partnerID=8YFLogxK

U2 - 10.4196/kjpp.2011.15.1.61

DO - 10.4196/kjpp.2011.15.1.61

M3 - Article

C2 - 21461242

AN - SCOPUS:79953121218

VL - 15

SP - 61

EP - 66

JO - Korean Journal of Physiology and Pharmacology

JF - Korean Journal of Physiology and Pharmacology

SN - 1226-4512

IS - 1

ER -